LB Pharmaceuticals LBRX
$38.85 −$1.19 (-2.97%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $38.85 0.00%
Open$39.53
Prev close$40.04
Day range$38.57 – $40.67
Volume303.1K
Market cap$1.26B
P/E (TTM)38.3
Dividend yield–
LBRX Stock News
Headlines matching LB Pharmaceuticals or the LBRX ticker, most recent first.
- Piper Sandler Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $78
- Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX)
- H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $60 Positive
- Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $69
- Clear Street Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $69 Positive
- Stifel Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Raises Target Price to $53 Positive
- Analysts Offer Insights on NA Companies: AEVEX Corp. Class A (AVEX), LB Pharmaceuticals, Inc. (LBRX) and BETA Technologies, Inc. Class A (BETA)
- Craig-Hallum Remains a Buy on LB Pharmaceuticals, Inc. (LBRX)
- Earnings Flash (LBRX) LB Pharmaceuticals Posts Q2 Loss $1.71 a Share, Vs. FactSet Est of $0.81 Loss Negative
- Wolfe Research Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
- Analysts Offer Insights on NA Companies: Exodus Movement, Inc. Class A (EXOD) and LB Pharmaceuticals, Inc. (LBRX)
- LB Pharmaceuticals, Inc. (LBRX) Gets a Buy From H.C. Wainwright
- Craig-Hallum Maintains LB Pharmaceuticals(LBRX.US) With Buy Rating, Maintains Target Price $36
- Clear Street Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $45
No comments yet — be the first to weigh in on LBRX.
Sign in to join the discussion.